Holen Sie sich die Stockscreener-App
3.00
6.01%
0.17
Insight Molecular Diagnostics Inc Aktie (IMDX) Neueste Nachrichten
US Stocks Starting with I: Complete List - INDmoney
Insight Molecular Diagnostics Inc. Announces Appointment of Donnie Purto as Senior Vice President of Sales - marketscreener.com
Insight Molecular Diagnostics (NasdaqCM:IMDX) Stock Forecast & Analyst Predictions - Simply Wall Street
iMDx to Participate in Virtual U.S. Bancorp I BTIG Kidney Health Forum with KOL Discussion and Investor Meetings - The Manila Times
IMDX : Insight Molecular Diagnostics Inc. Key Company Metrics & Non-finance Metrics - Zacks Investment Research
Retractable Technologies, Inc. (RVP) Stock Price, News, Quote & History - Yahoo! Finance Canada
Insight Molecular (IMDX) shifts Chronix earnout to CNI Monitor test - Stock Titan
Myriad Genetics (NASDAQ: MYGN) swaps commercial chief but keeps 2026 outlook - Stock Titan
Insight Molecular Diagnostics Inc (OCX) Stock Price Quote Today & Current Price Chart - Capital.com
Medicare policy boosts iMDx transplant testing frequency - scanx.trade
Insight Molecular Diagnostics Inc. (IMDX) Slips 1.94% to $4.04 as Key Support HoldsGamma Squeeze - dars.gov.et
iMDx executives are set to meet investors in New York - Stock Titan
iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference - GlobeNewswire
Here's Why We're A Bit Worried About Insight Molecular Diagnostics' (NASDAQ:IMDX) Cash Burn Situation - Simply Wall Street
IMDX Q2 2026 Earnings: Wider-than-Expected Loss Sends Shares Down 3.73%Net Profit Margin - dars.gov.et
IMDX Q2 2026 Earnings: Wider-than-Expected Loss Sends Shares Down 3.73%EPS Growth Rate - https://www.dars.gov.et/
Guardant Health Inc (NASDAQ: GH) Share Price, GH Stock News, GH Share Price & Updates - kalkine.ca
Insight (IMDX) Earnings Report: Profit Per Share Surpasses Its Benchmark at the Close; Trading Response - careplusvn.com
Analysts Have Conflicting Sentiments on These Healthcare Companies: Lexicon Pharmaceuticals (LXRX) and MaxCyte (MXCT) - The Globe and Mail
Lucid Capital Markets initiates Insight Molecular stock with buy rating By Investing.com - Investing.com Nigeria
Lucid Capital Markets initiates Insight Molecular stock with buy rating By Investing.com - Investing.com UK
Insight Molecular Q2FY26 Results: Cash burn rises to $10 million - scanx.trade
Lucid Capital Markets initiates Insight Molecular stock with buy rating - Investing.com
Insight Molecular Diagnostics Earnings Call Balances Risk - TipRanks
Insight (IMDX) Price: Adds 2.34% to Close at $4.38 in Latest Trading; Price Levels: the $4.16 to $4.60 Range Remains in Focus in the Current UpdateTriangle Correction - vinanet.vn
Insight (IMDX) Price: Adds 2.34% to Close at $4.38 in Latest Trading; Price Levels: the $4.16 to $4.60 Range Remains in Focus in the Current UpdateHigh Low Breadth - siam.in
Insight (IMDX) Earnings Brief: The Bottom-Line Figure Outpaces Its Comparison in Latest Trading; Market Read: The Stock Gains 0.23% at the CloseEarnings Surprise Score - vinanet.vn
symbol__ Stock Quote Price and Forecast - CNN
Lake Street Maintains Insight Molecular Diagnostics(IMDX.US) With Buy Rating, Maintains Target Price $12 - Moomoo
IMDX Reiterated by Needham -- Price Target Maintained at $9.00 - GuruFocus
Needham Maintains Insight Molecular Diagnostics(IMDX.US) With Buy Rating, Maintains Target Price $9 - Moomoo
Insight Molecular Diagnostics (IMDX) Q2 2026 Earnings Call Transcript - The Globe and Mail
Insight Molecular Diagnostics advances heart tr... - Pluang
Insight Molecular Diagnostics (IMDX) Q2 2026 Earnings Call Transcript - The Globe and Mail
Insight Molecular Diagnostics (IMDX) Q2 2026 Earnings Call Transcript - The Globe and Mail
Veterinary Diagnostics Market Share | Industry Report [2034] - Fortune Business Insights
MDxHealth (MDXH) Surges 74.89% to $0.81 as Momentum Builds in Diagnostic OncologySynthetic Short - careplusvn.com
Insight Molecular Diagnostics Inc. (IMDX) - Zacks Investment Research
Cardio Diagnostics Holdings Warrant (CDIOW) Holds at $0.01 as Trading Remains Highly SpeculativeMAMA Signal - careplusvn.com
Cardio Diagnostics Holdings Warrant (CDIOW) Holds at $0.01 as Trading Remains Highly SpeculativeFundamentals - dars.gov.et
Cardio Diagnostics Holdings Warrant (CDIOW) Holds at $0.01 as Trading Remains Highly SpeculativeReversal Setup Alerts - dars.gov.et
Insight Molecular Diagnostics (IMDX) Drops 6.4% to $4.21 as Sellers Target $4.00 SupportDescending Triangle - dars.gov.et
Insight Molecular Diagnostics (IMDX) Drops 6.4% to $4.21 as Sellers Target $4.00 SupportDescending Triangle - dars.gov.et
Insight Molecular Diagnostics (IMDX) Drops 6.4% to $4.21 as Sellers Target $4.00 SupportMomentum Stock Picks - vinanet.vn
Rest-Of-Europe Molecular Cytogenetics Market Size, Share,Trends, Growth Analysis Report, 2030 - MarketsandMarkets
Germany Molecular Cytogenetics Market Size, Share,Trends, Growth Analysis Report, 2030 - marketsandmarkets.com
Insight Molecular Diagnostics (IMDX) Drops 6.4% to $4.21 as Sellers Target $4.00 SupportEarnings Miss Risk - dars.gov.et
OCX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Insight Molecular Diagnostics to Host Virtual KOL Event on - GlobeNewswire
Lake Street Maintains Insight Molecular Diagnostics(IMDX.US) With Buy Rating, Maintains Target Price $12 - Moomoo
5.67%
6.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):